Steven Erwood

617 total citations
12 papers, 356 citations indexed

About

Steven Erwood is a scholar working on Molecular Biology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Steven Erwood has authored 12 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Epidemiology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Steven Erwood's work include CRISPR and Genetic Engineering (6 papers), Cytomegalovirus and herpesvirus research (3 papers) and Hedgehog Signaling Pathway Studies (2 papers). Steven Erwood is often cited by papers focused on CRISPR and Genetic Engineering (6 papers), Cytomegalovirus and herpesvirus research (3 papers) and Hedgehog Signaling Pathway Studies (2 papers). Steven Erwood collaborates with scholars based in Canada, United States and Sweden. Steven Erwood's co-authors include Evgueni A. Ivakine, Ronald D. Cohn, Laurence Pelletier, Onofrio Laselva, Christine E. Bear, Dwi U. Kemaladewi, Ryan M. Marks, Steven A. Prescott, Madeleine Durbeej and Elzbieta Hyatt and has published in prestigious journals such as Nature, Nature Biotechnology and Development.

In The Last Decade

Steven Erwood

12 papers receiving 353 citations

Peers

Countries citing papers authored by Steven Erwood

Since Specialization

Citations

This map shows the geographic impact of Steven Erwood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Erwood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Erwood more than expected).

Fields of papers citing papers by Steven Erwood

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Erwood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Erwood. The network helps show where Steven Erwood may publish in the future.

Co-authorship network of co-authors of Steven Erwood

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Erwood. A scholar is included among the top collaborators of Steven Erwood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Erwood. Steven Erwood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Prime editing-installed suppressor tRNAs for disease-agnostic genome editing 2025 ·Nature ·Sarah E. Pierce, Steven Erwood, (unknown), Meirui An, N Krasnow, (unknown), Aditya Raguram, Davis Seelig, Mark J. Osborn, David R. Liu	1
2	Species-specific differences in NPC1 protein trafficking govern therapeutic response in Niemann-Pick type C disease 2022 ·JCI Insight ·Mark L. Schultz, (unknown), (unknown), (unknown), Steven Erwood, Evgueni A. Ivakine, Nicole Y. Farhat, Forbes D. Porter, (unknown), Stephanie M. Cologna, Michael D. Uhler, Andrew P. Lieberman	6
3	Saturation variant interpretation using CRISPR prime editing 2022 ·Nature Biotechnology ·Steven Erwood, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Laurence Pelletier, Evgueni A. Ivakine, Ronald D. Cohn	99
4	STAT1 gain-of-function heterozygous cell models reveal diverse interferon-signature gene transcriptional responses 2021 ·npj Genomic Medicine ·Ori Scott, (unknown), Steven Erwood, (unknown), Chaim M. Roifman, Ronald D. Cohn, Evgueni A. Ivakine	12
5	Allele-Specific Prevention of Nonsense-Mediated Decay in Cystic Fibrosis Using Homology-Independent Genome Editing 2020 ·Molecular Therapy — Methods & Clinical Development ·Steven Erwood, Onofrio Laselva, (unknown), (unknown), (unknown), Christine E. Bear, Evgueni A. Ivakine	33
6	Embryo-Based Large Fragment Knock-in in Mammals: Why, How and What’s Next 2020 ·Genes ·Steven Erwood, Bin Gu	6
7	Modeling Niemann–Pick disease type C in a human haploid cell line allows for patient variant characterization and clinical interpretation 2019 ·Genome Research ·Steven Erwood, (unknown), (unknown), (unknown), (unknown), Ronald D. Cohn, Evgueni A. Ivakine	14
8	Anti-CRISPR AcrIIA5 Potently Inhibits All Cas9 Homologs Used for Genome Editing 2019 ·Cell Reports ·Bianca Garcı́a, Jooyoung Lee, Alireza Edraki, (unknown), Steven Erwood, Aamir Mir, (unknown), Uri Seroussi, Sabrina Y. Stanley, Ronald D. Cohn, Julie M. Claycomb, Erik J. Sontheimer, Karen L. Maxwell, Alan R. Davidson	36
9	A mutation-independent approach for muscular dystrophy via upregulation of a modifier gene 2019 ·Nature ·Dwi U. Kemaladewi, (unknown), Steven Erwood, (unknown), Kinga I. Gawlik, (unknown), Elzbieta Hyatt, (unknown), (unknown), Ryan M. Marks, Madeleine Durbeej, Steven A. Prescott, Evgueni A. Ivakine, Ronald D. Cohn	100
10	Activity of lumacaftor is not conserved in zebrafish Cftr bearing the major cystic fibrosis‐causing mutation 2019 ·FASEB BioAdvances ·Onofrio Laselva, Steven Erwood, Kai Du, Evgueni A. Ivakine, Christine E. Bear	16
11	Hedgehog-GLI signaling inFoxd1-positive stromal cells promotes nephrogenesis Via TGFβ signaling 2018 ·Development ·Christopher J. Rowan, (unknown), (unknown), Steven Erwood, Di Hu, (unknown), (unknown), Jaap Mulder, (unknown), Lin Chen, Norman D. Rosenblum	25
12	Suppressor of fused controls cerebellar neuronal differentiation in a manner modulated by GLI3 repressor and Fgf15 2017 ·Developmental Dynamics ·(unknown), (unknown), Steven Erwood, (unknown), Norman D. Rosenblum	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact